Fisher Kenneth R's Form 4 filing
Bluejay Diagnostics, Inc. (BJDX) · filed Sep 7, 2022
- Accession no.
- 0001213900-22-054434
- Filed
- Sep 7, 2022
- Trade date
- Aug 26, 2022
- Filing delay
- 12 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $20.6K. It was filed 12 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Fisher Kenneth RCIK 0001812485 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 26, 2022 | Common Stock | PPurchaseAcquired | +20,000 | $1.03 | +$20,600 | 40,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.